CS241549B2 - Method of 1,4-dihydropyridines production - Google Patents

Method of 1,4-dihydropyridines production Download PDF

Info

Publication number
CS241549B2
CS241549B2 CS845570A CS557084A CS241549B2 CS 241549 B2 CS241549 B2 CS 241549B2 CS 845570 A CS845570 A CS 845570A CS 557084 A CS557084 A CS 557084A CS 241549 B2 CS241549 B2 CS 241549B2
Authority
CS
Czechoslovakia
Prior art keywords
sub
alkyl
pyrimidone
group
formula
Prior art date
Application number
CS845570A
Other languages
Czech (cs)
English (en)
Other versions
CS557084A2 (en
Inventor
David Alker
Peter E Cross
Simon F Campbell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838319886A external-priority patent/GB8319886D0/en
Priority claimed from GB848400354A external-priority patent/GB8400354D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of CS557084A2 publication Critical patent/CS557084A2/cs
Publication of CS241549B2 publication Critical patent/CS241549B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
CS845570A 1983-07-23 1984-07-19 Method of 1,4-dihydropyridines production CS241549B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838319886A GB8319886D0 (en) 1983-07-23 1983-07-23 Therapeutic agents
GB848400354A GB8400354D0 (en) 1984-01-07 1984-01-07 Therapeutic agents

Publications (2)

Publication Number Publication Date
CS557084A2 CS557084A2 (en) 1985-07-16
CS241549B2 true CS241549B2 (en) 1986-03-13

Family

ID=26286678

Family Applications (1)

Application Number Title Priority Date Filing Date
CS845570A CS241549B2 (en) 1983-07-23 1984-07-19 Method of 1,4-dihydropyridines production

Country Status (21)

Country Link
US (1) US4568677A (de)
EP (1) EP0132375B1 (de)
AT (1) ATE44146T1 (de)
AU (1) AU547188B2 (de)
CA (1) CA1265796A (de)
CS (1) CS241549B2 (de)
DD (1) DD226285A5 (de)
DE (1) DE3478746D1 (de)
DK (1) DK170069B1 (de)
ES (1) ES8700856A1 (de)
FI (1) FI79105C (de)
GR (1) GR82230B (de)
HU (1) HU212133B (de)
IE (1) IE58443B1 (de)
IL (1) IL72475A (de)
NO (1) NO161174C (de)
NZ (1) NZ208954A (de)
PH (1) PH20479A (de)
PL (1) PL142659B1 (de)
PT (1) PT78958B (de)
YU (1) YU43738B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GR851819B (de) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
GB8501395D0 (en) * 1985-01-19 1985-02-20 Pfizer Ltd Dihydropyridine anti-ischaemic & anti-hypertensive agents
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
JPS61227567A (ja) * 1985-04-01 1986-10-09 Eisai Co Ltd 1,4−ジヒドロピリジン誘導体
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents
EP0225175A3 (de) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4654372A (en) * 1986-01-10 1987-03-31 Warner-Lambert Company Method for using verapamil for treating stroke
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
IT1197012B (it) * 1986-07-29 1988-11-25 Boehringer Biochemia Srl 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
WO2004033444A1 (en) * 2002-10-07 2004-04-22 Artesian Therapeutics, Inc. Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity
US20070066619A1 (en) * 2002-10-07 2007-03-22 Artesian Therapeutics, Inc. Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
JP2008519850A (ja) * 2004-11-10 2008-06-12 シンタ ファーマシューティカルズ コーポレーション Il−12調節化合物
CN115557883A (zh) * 2022-10-28 2023-01-03 常州制药厂有限公司 一种氨氯地平的合成工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
EP0107293A3 (de) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridine
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HUT36113A (en) 1985-08-28
FI79105B (fi) 1989-07-31
CS557084A2 (en) 1985-07-16
HU212133B (en) 1996-05-28
YU130584A (en) 1986-12-31
US4568677A (en) 1986-02-04
AU3089984A (en) 1985-01-24
IL72475A (en) 1987-10-20
DE3478746D1 (en) 1989-07-27
FI79105C (fi) 1989-11-10
PH20479A (en) 1987-01-16
PL248857A1 (en) 1985-08-27
NO161174B (no) 1989-04-03
PL142659B1 (en) 1987-11-30
DK170069B1 (da) 1995-05-15
CA1265796A (en) 1990-02-13
NZ208954A (en) 1986-11-12
NO842987L (no) 1985-01-24
ES534505A0 (es) 1986-11-16
PT78958B (en) 1986-10-21
PT78958A (en) 1984-08-01
DK355784D0 (da) 1984-07-20
YU43738B (en) 1989-10-31
FI842911A0 (fi) 1984-07-19
DD226285A5 (de) 1985-08-21
EP0132375B1 (de) 1989-06-21
NO161174C (no) 1989-07-12
GR82230B (de) 1984-12-13
IL72475A0 (en) 1984-11-30
ES8700856A1 (es) 1986-11-16
IE841905L (en) 1985-01-23
IE58443B1 (en) 1993-09-22
EP0132375A2 (de) 1985-01-30
EP0132375A3 (en) 1987-07-01
FI842911A (fi) 1985-01-24
AU547188B2 (en) 1985-10-10
DK355784A (da) 1985-01-24
ATE44146T1 (de) 1989-07-15

Similar Documents

Publication Publication Date Title
CS241549B2 (en) Method of 1,4-dihydropyridines production
US4939137A (en) Ring-fused thienopyrimidinedione derivatives
JP2528218B2 (ja) ピリミジン誘導体
CS247073B2 (en) Production method of 2-substituted 4-amino-6,7-dimethoxyghinolins
EP0094159A1 (de) Dihydropyridinderivate, deren Herstellung und Verwendung
CZ277698B6 (en) Racemic or optically active bis-aza-bicyclic compounds, process for preparing thereof, intermediates and use thereof
CS249516B2 (en) Method of dihydropiridines production
EP0172029B1 (de) 1,4-Dihydropyridine
NZ202959A (en) N-oxido-pyridyl-pyridine derivatives and pharmaceutical compositions
US6103724A (en) 2-methoxyphenylpiperazine derivatives
JPS60214778A (ja) Ν置換3,4−ジヒドロピリミジン誘導体ならびにその製造法および用途
US4529730A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
CS255897B2 (en) Process for preparing 1,2,4-triazolocarbamates
EP0257616A2 (de) Dihydropyridinderivate und deren pharmazeutische Zusammensetzungen
JPS6024794B2 (ja) オキサジアゾロピリミジン誘導体
US5364860A (en) Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions
JP2640245B2 (ja) 1,4−ジヒドロピリジン誘導体
US5441948A (en) 1,3,4-benzotraizepin-5(4H)-one derivatives and process for the preparation thereof
CS248718B2 (en) Production method of the triazolo-pyrimidine derivatives
JPS63243073A (ja) 2−チオメチル−置換ピリジン、その製造方法、及び該ピリジンを含有する薬剤組成物
US5158963A (en) 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
JPS61167683A (ja) ジヒドロピリジン抗虚血および抗高血圧剤
US4639457A (en) Benzocycloheptapyridone compounds for treating congestive heart failure
CS270242B2 (en) Method of dihydropyridines production
EP0165032A2 (de) Anti-ischämische und Antihypertensive Dihydropyridine